Intravenous Usage of Gammaglobulin: Humoral Immunodeficiency, Immune Thrombocytopenic Purpura, and Newer Indications
- 1 January 1985
- journal article
- research article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 3 (4) , 361-366
- https://doi.org/10.3109/07357908509039797
Abstract
(1985). Intravenous Usage of Gammaglobulin: Humoral Immunodeficiency, Immune Thrombocytopenic Purpura, and Newer Indications. Cancer Investigation: Vol. 3, No. 4, pp. 361-366. doi: 10.3109/07357908509039797Keywords
This publication has 8 references indexed in Scilit:
- THE USE AND MECHANISM OF ACTION OF INTRAVENOUS IMMUNOGLOBULIN IN THE TREATMENT OF IMMUNE HAEMATOLOGIC DISEASEBritish Journal of Haematology, 1984
- Intravenous use of gammaglobulin in the treatment of chronic immune thrombocytopenic purpura as a means to defer splenectomyThe Journal of Pediatrics, 1983
- Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpuraBlood, 1983
- Reversal of neutropenia with intravenous gammaglobulin in autoimmune neutropenia of infancyBlood, 1983
- EFFECT OF INTRAVENOUS IMMUNOGLOBULIN IN IMMUNE THROMBOCYTOPENIA: Competitive Inhibition of Reticuloendothelial System Function by Sequestration of Autologous Red Blood Cells?The Lancet, 1983
- Monomeric IgG preparations for intravenous use inhibit platelet stimulation by polymeric IgGBritish Journal of Haematology, 1983
- Use of intravenous γ-globulin in antibody immunodeficiency: Results of a multicenter controlled trialClinical Immunology and Immunopathology, 1982
- Intravenous Administration of Human γ‐Globulin*Vox Sanguinis, 1962